As shown in Fig. 6A, intravenous administration of GAS6-CAR-T cells led to a significant suppression of pancreatic cancer PDX tumor growth, while tumors in the Mock group continued to grow rapidly. The gene discussed is GAS6; the disease is pancreatic neoplasm.